liposome-encapsulated daunorubicin-cytarabine, fludarabine phosphate, cytarabine, and filgrastim
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for liposome-encapsulated daunorubicin-cytarabine, fludarabine phosphate, cytarabine, and filgrastim, covering 2019-12-30 to 2019-12-30. Get the full timeline:
Most recent: Clinical Trial Update: Liposome-encapsulated Daunorubicin-Cytarabine, Fludarabine Phosphate, Cytarabine, and Filgrastim in Treating Younger Patients With Relapsed or Refractory Acute Myeloid Leukemia [Phase 1, Phase 2]